1 Dec 2025
IgA Nephropathy prognosis has improved with new 2025 guidelines. Learn the latest treatments like Nefecon, SGLT2 inhibitors, and proteinuria targets that can prevent kidney failure.
View More
1 Dec 2025
When should you treat elevated TSH if your thyroid hormones are normal? Learn evidence-based guidelines for subclinical hypothyroidism, who benefits from levothyroxine, and why antibody status matters more than the number.
View More
29 Nov 2025
Digital mental health apps and teletherapy are growing fast, but not all are effective or safe. Learn what works, what to watch out for, and how to protect your privacy when using mental health technology in 2025.
View More
29 Nov 2025
NSAID-sensitive asthma, or NERD, affects 7% of asthma patients and can trigger life-threatening reactions. Learn the signs, hidden sources of NSAIDs, safe pain relief options, and how aspirin desensitization can help.
View More
27 Nov 2025
Generic drug classifications organize medications by therapeutic use, mechanism of action, legal status, and cost tiers. Learn how systems like FDA categories, DEA schedules, ATC codes, and insurance tiers impact your prescriptions and healthcare costs.
View More
26 Nov 2025
Annual savings from FDA generic drug approvals hit $445 billion in 2023, with year-to-year variation driven by patent expirations. Learn how generics cut drug costs, who benefits, and why savings spike in some years.
View More
25 Nov 2025
Managing therapeutic equivalence in combination products requires careful evaluation of active ingredients, dosage forms, and bioequivalence. Learn how FDA ratings, dose interactions, and NTI drugs impact substitution safety and patient outcomes.
View More
24 Nov 2025
C. diff colitis is often triggered by antibiotics, leading to severe diarrhea and recurrent infections. Fecal transplants offer a highly effective cure for recurring cases by restoring healthy gut bacteria.
View More
23 Nov 2025
Learn how to confirm pharmacist counseling notes after picking up your prescription. Get step-by-step methods to access written guidance, avoid medication errors, and protect your health-no matter which pharmacy you use.
View More
20 Nov 2025
When antihistamines fail for chronic spontaneous urticaria, second-line treatments like omalizumab, remibrutinib, and dupilumab offer real hope. Learn which options work best based on your subtype and symptoms.
View More